Some Labs Using Beckman's Troponin Kits Get Reprieve as May 31 Deadline Passes

The FDA allowed Beckman to continue selling its troponin test kits to customers currently using its Access instruments for as long as it takes Beckman to receive an updated 510(k) clearance for the tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.